Related Experiment Video
Updated: Jun 3, 2026

Analysis of Nephron Composition and Function in the Adult Zebrafish Kidney
Published on: August 9, 2014
Can the nephron be spared?
1Cleveland Clinic Lerner College of Medicine, Glickman Urological and Kidney Institute, Cleveland, Ohio 44195, USA. flechns@ccf.org
Abstract:
The search continues for the best role for mTOR inhibitor drugs in renal transplantation-principally to avoid or minimize the nephrotoxicity of the CNI class of immunosuppressive agents. The Spare the Nephron Trial describes the popular approach of early conversion from a CNI to the mTOR agent sirolimus for patients maintained on mycophenolate mofetil and steroids. At 1-2 years the glomerular filtration rate (GFR) was superior for the sirolimus group, with a loss of tolerability for about 20%.
Insights
The Spare the Nephron Trial found early conversion to sirolimus improved kidney function after transplantation compared to calcineurin inhibitors (CNIs). Some patients experienced sirolimus tolerability issues.
Area of Science:
- Nephrology
- Immunosuppression
- Transplantation medicine
Background:
- Calcineurin inhibitors (CNIs) are standard immunosuppressants in renal transplantation but cause nephrotoxicity.
- Mammalian target of rapamycin (mTOR) inhibitors offer an alternative immunosuppressive strategy.
- Minimizing CNI-induced nephrotoxicity is crucial for long-term graft survival.
Purpose of the Study:
- To evaluate the efficacy and safety of early conversion from CNIs to an mTOR inhibitor (sirolimus) in renal transplant recipients.
- To assess the impact of this conversion strategy on renal function and graft outcomes.
Main Methods:
- The Spare the Nephron Trial involved patients maintained on mycophenolate mofetil and steroids.
- Participants underwent early conversion from CNIs to sirolimus.
- Renal function, assessed by glomerular filtration rate (GFR), was monitored over 1-2 years.
Main Results:
- Patients converted to sirolimus demonstrated superior glomerular filtration rates (GFR) at 1-2 years post-transplantation.
- Approximately 20% of patients experienced a loss of tolerability to sirolimus.
- The study highlights a trade-off between improved renal function and potential adverse effects.
Conclusions:
- Early conversion to sirolimus can improve renal function in renal transplant recipients.
- Sirolimus represents a viable alternative to CNIs for minimizing nephrotoxicity.
- Careful patient selection and monitoring are necessary due to potential tolerability issues with sirolimus.
Related Concept Videos
Nephrons
Kidney Structure
Renal Drug Excretion: Overview
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules out...
Drug Elimination by Renal Route: Glomerular Filtration
Filtration and Urine Formation
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

